- QMRO Home
- William Harvey Research Institute
- Centre for Clinical Pharmacology
- Mineralocorticoid receptor antagonist pre-treatment and early post-treatment to minimize reperfusion injury after ST-elevation myocardial infarction: The MINIMIZE STEMI tria
Browse
Administrators only